A

Alexion

Global biopharmaceuticals focusing on rare diseases

Associate Director - RDU IT, MLOps

Applied Machine LearningConfirmed live in the last 24 hours
Full-timeBarcelona, SpainNo salary listed

About the Job

Requirements

  • A Bachelor's degree in Computer Science, Electrical Engineering, Mathematics, Statistics, or a related field is required.
  • At least 8 years of experience in software, cloud, DevOps, or AI/ML engineering is required.
  • At least 4 years of experience deploying and maintaining machine learning models in production is required.
  • Proven technical leadership experience delivering platform capabilities is required.
  • Hands-on experience building production models with data science operations, serverless architectures, Kubernetes, Docker/containerization, and model upkeep and maintenance is required.
  • Hands-on experience using Terraform and Terragrunt for infrastructure as code to provision and manage secure, repeatable cloud environments is required.
  • Familiarity with API-based application architecture and API frameworks is required.
  • Experience with continuous integration and continuous delivery orchestration frameworks such as GitHub Actions, Jenkins, or Bitbucket Pipelines is required.
  • A deep understanding of the software development lifecycle and maintenance is required.
  • Extensive experience with orchestration tools such as Airflow, Flyte, or Kubeflow is required.
  • Extensive experience with vector databases, retrieval-augmented generation patterns, LangChain- or LlamaIndex-class frameworks, evaluation harnesses, and prompt and guardrail management is required.
  • Experience with MLOps tools for experiment tracking, model registries, and feature stores, such as MLflow, SageMaker, or Azure, is required.
  • Strong Python programming skills and experience with TensorFlow, Keras, or PyTorch are required.
  • Proficiency in MLOps best practices, including model training, testing, deployment, and monitoring, is required.
  • Experience with cloud computing platforms such as AWS, Azure, or GCP is required.
  • A strong understanding of software engineering best practices and agile methodologies is required.
  • A strong understanding of data structures, algorithms, and machine learning techniques is required.
  • The ability to work effectively in a cross-functional team environment is required.
  • The ability to work independently and demonstrate self-direction and problem-solving is required.
  • Fluency in English is required.

Responsibilities

  • Own the product vision, target architecture, roadmap, and engineering delivery for the RDU AI/ML platform, including reusable frameworks, reference architectures, APIs, templates, and self-service paved-road services.
  • Prioritize platform capabilities based on user needs, enterprise standards, and measurable business outcomes; lead solution design decisions and trade-offs across security, integration, data, performance, scalability, interoperability, and cost in alignment with Enterprise Architecture.
  • Ensure the platform is secure, resilient, scalable, and cost-effective through infrastructure as code, service-level objectives, monitoring, incident management, capacity planning, and disaster recovery for production-grade machine learning, agentic AI, and generative AI workloads.
  • Define, implement, and govern engineering standards and reusable delivery patterns across AI workstreams, including secure continuous integration and continuous delivery, automated testing, code quality, vulnerability management, release controls, observability, and production support.
  • Foster innovation through rapid experimentation, evaluation of emerging technologies, and responsible adoption of proven approaches; use engineering metrics and assurance reviews to drive adoption and continuous improvement.
  • Lead solution design discussions, translate business and technical requirements into robust, fit-for-purpose solutions, and own solution decisions and trade-offs aligned with Enterprise Architecture.
  • Lead engineering teams and communicate solution decisions, delivery progress, risks, and outcomes to stakeholders and senior management to ensure alignment and timely decisions.
  • Own the architecture, development, and governance of MLOps and LLMOps pipelines; automate model and LLM workflows and integrate them securely with enterprise data, applications, and IT systems.
  • Own the platform cost model and financial transparency, track cost per inference, GPU utilization, and token economics, and operate showback and chargeback mechanisms for internal consumers to drive year-on-year unit cost reduction.
  • Embed security, privacy, data governance, model risk management, and responsible AI controls into platform capabilities and solution lifecycles.
  • Ensure proportionate validation, documentation, human oversight, traceability, and auditability in accordance with business needs, GxP requirements, and applicable regulatory standards.
  • Champion the responsible adoption of AI across RDU IT and embed practical AI capabilities into day-to-day workflows to improve productivity, decision-making, collaboration, and service delivery.
  • Drive the adoption of AI-infused capabilities across IT operations, including observability, AIOps, AgentOps, and service management, in alignment with Enterprise Architecture, IT, and EAI; deliver reusable solutions that improve resilience, efficiency, and engineering productivity.

Desired Qualifications

  • Experience in the pharmaceutical industry or related fields is desirable.
  • A Master's degree in a related field or ongoing education toward an advanced degree is desirable.
  • Strong knowledge of AI techniques and tools, including natural language processing, optimization, and deep learning, is desirable.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs